INTRODUCTION
Birt-Hogg-Dubé (BHD) syndrome is a rare autosomal-dominant disorder that affects lung, skin, and kidney (Birt et al., 1977) . In the lung, 80%-100% of patients with BHD develop multiple thin-wall cysts without evidence of neoplasia, inflammation, or fibrosis (Gupta et al., 2013) . Cyst rupture and lung collapse cause spontaneous and recurrent pneumothoraces (Gupta et al., 2013) . In contrast to lung, FLCN mutations in the kidney result in bilateral multifocal renal cell carcinomas (Schmidt, 2004) , and in hair follicles result in hamartomas (fibrofolliculomas). The mechanism by which the loss of FLCN promotes the development of cysts but not neoplasia is unknown.
Genetic mapping in families with BHD identified the Folliculin (FLCN) gene locus (Nickerson et al., 2002; Schmidt et al., 2001) . Loss of heterozygosity in BHD lesions supports a tumor suppressor function for FLCN (Vocke et al., 2005) . Homozygous Flcn À/À mice are embryonically lethal, and heterozygous Flcn +/À mice develop kidney tumors without lung pathology (Hasumi et al., 2009) . In Drosophila and yeast, FLCN is involved in the mammalian target of rapamycin signaling pathway and in energy metabolism (Liu et al., 2013; van Slegtenhorst et al., 2007) . Inactivation of FLCN induces mitochondrial gene expression (Hasumi et al., 2012) . Studies also suggest crosstalk of FLCN with the master energy sensor AMP-activated protein kinase (AMPK) via FLCN-interacting proteins FNIP1 and FNIP2 (Baba et al., 2006; Hasumi et al., 2008; Takagi et al., 2008) . How these signaling events relate to FLCN function in normal lung or in pulmonary cyst development in BHD is unknown. The prevailing hypothesis used to explain the development of emphysematous alveolar enlargement and cyst formation in lung diseases involves an imbalance between matrix degrading matrix metalloproteinases (MMPs) and their endogenous inhibitors the tissue inhibitor of metalloproteinases (Shapiro and Ingenito, 2005; Suki et al., 2003) . The notion, however, that alveolar epithelial cell (AEC) apoptosis is a primary event in the pathogenesis of alveolar enlargement related to lung injury has become an area of significant interest (Henson and Tuder, 2008; Mouded et al., 2009 ). The FLCN-dependent mechanism of cystic lung enlargement in BHD and the functional significance of FLCN inactivation in the lung remain uncharacterized.
Cell-cell and cell-matrix interactions are critical components of epithelial cell survival, and disruption of these interactions often leads to caspase-mediated apoptosis (Frisch and Screaton, 2001) . AMPK is required for cell survival and for the maintenance of epithelial cell junctions (Hardie, 2011; Lee et al., 2008; Liu et al., 2010; Zheng and Cantley, 2007) . AMPK activity is regulated through phosphorylation by LKB1 (Hardie, 2011) , a tumor suppressor gene associated with 30% of lung cancers (Makowski and Hayes, 2008) . LKB1 controls the maturation of apical junctions in human bronchial epithelial cells (Xu et al., 2013). E-cadherin regulates the localization of LKB1 to epithelial cell junctions, and loss of E-cadherin impairs LKB1-mediated AMPK activation (Sebbagh et al., 2009 ).
These observations raise the possibility that FLCN might be involved in the regulation of AMPK signaling in AECs and that inactivating mutation of FLCN might impair epithelial cell junctions and cell survival. In this study, we investigate this possibility with cell-type-specific inducible Flcn deletion in mouse lung epithelium and with FLCN-null human and mouse epithelial cell systems.
RESULTS

Loss of Flcn in Lung Epithelium Results in Increased Alveoli
Hematoxylin and eosin (H&E) staining of control human lung reveals typical lung structure ( Figure 1A , left). In contrast, lungs from patients with BHD showed irregular and disrupted lung parenchyma ( Figure 1A , right). Healthy alveoli are lined with type I and the surfactant protein C (SP-C)-expressing type II AECs (Figures S1A and S1B), a renewable population of progenitors in these distal airspaces. We used coimmunostaining to determine FLCN expression in human lung from healthy controls and subjects with BHD. In control lung, FLCN staining colocalizes with SP-C expression in AECs ( Figure 1B, top) . Coimmunostaining of lung tissue from patients with BHD detects very little FLCN in alveolar SP-C-positive cells ( Figure 1B, bottom) . with SP-C-rtTA/tetO-Cre (line 2) mice (Perl et al., 2009 ) ( Figure S1C ) to generate Flcn f/f :SP-C-Cre mice with inducible Flcn deletion in SP-C-expressing cells by a dietary supplementation with doxycycline (Dox) starting at 6 weeks of age. Under this SP-C promoter, Cre expression is targeted to the AECs in alveoli and peripheral bronchioles (Perl et al., 2009 2C , and S1D-S1F). However, the overall structure and organization of the lungs are nearly normal. The lung alveoli of Flcn 
FLCN Is Required for Postnatal Lung Alveolarization
To determine the role of FLCN during lung development, female Flcn f/f :SP-C-Cre mice were placed on a Dox-supplemented diet starting at embryonic day 0.5 (E0.5). Newborn pups were viable and appeared normal with no increased perinatal lethality. However, postnatal pups with lung epithelial-specific Flcn deletion exhibited larger alveoli compared to pups with Flcn-expressing lung epithelium ( Figures 2D-2F ). These data show developmental changes induced by FLCN deletion in lung epithelium and suggest a role for FLCN in branching morphogenesis of the lung. :CCSP-Cre mice did not result in differences in the lung function ( Figure S1I ) compared to age-and gender-matched controls. These results demonstrate that lung parenchyma and function are affected by Flcn deletion specifically in AECs expressing SP-C, and alveolar epithelium is vulnerable to loss of FLCN during early lung development as well as in the mature lung.
FLCN Regulates Lung Function
FLCN Is Required for AEC Survival In Vivo
To evaluate whether apoptosis plays a role in airspace enlargement in BHD, control and BHD human lung tissues were immunostained with cleaved caspase-3 antibody. As seen in Figure 2H , apoptotic SP-C-positive cells were detected in BHD lung, but not in control human lung. AECs positive for activated caspase-3 were identified in lungs of Flcn f/f :SP-C-Cre mice maintained on a Dox diet compared to age-and gendermatched littermates maintained on a regular diet ( Figure 2I ). Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining to assess DNA fragmentation was also detected in human BHD lungs and mouse lungs with deleted FLCN ( Figure S2 ). Importantly, TUNEL staining colocalizes with SP-C immunostaining ( Figure S2C ).
FLCN Downregulates LKB1 and Controls AMPK Activity
Because our results show that FLCN regulates AEC survival in vivo, we sought to identify the mechanism. AMPK activation is required to maintain epithelial cell-cell junctions, thus preserving epithelial barriers and promoting cell survival (Hardie, 2011) . To determine whether FLCN deficiency affects AMPK activation, we used the FLCN-null human epithelial renal tumor cell line UOK257 derived from the kidney tumor of a patient with BHD, and UOK257 cells with stably re-expressed FLCN (UOK257-2) used as a control (Baba et al., 2006) . AMPK is phosphorylated on Thr172 by LKB1 under conditions of stress, such as nutrient deprivation. Serum depletion of FLCN-expressing UOK257-2 cells for 24 and 48 hr resulted in time-dependent AMPK phosphorylation at Thr172 ( Figure 3A ). Phosphorylation of acetyl-coenzyme A-carboxylase (ACC) by activated AMPK also increased in a time-dependent manner in FLCN-expressing UOK257-2 cells. In contrast, FLCN-null cells exhibited reduced AMPK activation and ACC phosphorylation compared to FLCN-expressing UOK257-2 cells ( Figure 3A) . Importantly, serum deprivation also increased cleaved caspase-3 in FLCN-null UOK257 cells, but not in FLCN-expressing UOK257-2 cells ( Figure 3B ).
To further examine the effect of FLCN loss on AMPK activation in lung epithelial cells, we isolated primary mouse AECs from lungs of Flcn f/f :SP-C-Cre mice. Cells were treated with either an empty, replication-defective adenovirus or a replicationdefective adenovirus expressing Cre-recombinase to delete Flcn ( Figure 4A ). Immunostaining with antibody against T1a, an AEC marker (Ramirez et al., 2003) , showed T1a expression in primary mouse AECs from Flcn f/f :SP-C-Cre mice ( Figure S3 ). We next examined LKB1 levels in cells deficient for FLCN because LKB1 activates AMPK via phosphorylation at Thr172-AMPK (Hardie, 2011) . LKB1 levels were reduced in primary AECs after Flcn deletion ( Figure 4A ). LKB1 levels were also markedly decreased in NMuMG cells with Flcn knockdown induced by siRNA ( Figure 4B ). To further determine whether LKB1 expression is regulated by FLCN, FLCN-null UOK257 cells were transduced with replication-defective adenovirus expressing FLCN. FLCN re-expression in FLCN-null UOK257 cells significantly increased LKB1 levels ( Figure 4C ). Cellular fractionation showed significantly increased LKB1 levels induced by FLCN expression not only in cytosol but also in the membrane fraction ( Figure 4C ), confirming membrane localization of LKB1 (Sebbagh et al., 2009; Xu et al., 2013) . These data suggest that FLCN regulates the cellular level and localization of LKB1.
Regulation of E-Cadherin by FLCN Evidence demonstrates that E-cadherin regulates membrane localization of LKB1, which is critical for AMPK activation (Sebbagh et al., 2009) . Therefore, we determined whether Flcn deletion in primary AECs would affect E-cadherin expression and/or localization. E-cadherin is significantly decreased in the absence of Flcn expression ( Figures 5A-5C ). Immunostaining also showed marked reduction of E-cadherin in the adherens junctions of cellular membranes (Figure 5D , top; Figures S4A and S4C ). ZO-1 staining at tight junctions, however, appeared unchanged by Flcn deletion (Figure 5D , bottom; Figures S4B and S4C ). Thus, FLCN has a specific effect on E-cadherin expression and localization to adherens junctions.
To further determine FLCN's role in regulating E-cadherin, we used TSC2-null kidney epithelial cells, which have decreased membrane localization of E-cadherin ( Figure 5E ) Kleymenova et al., 2001) . Transient transfection of TSC2-null cells with myctagged FLCN ( Figure 5F ) increased Ecadherin membrane localization, which was statistically significant ( Figure 5G ). These data further suggest that FLCN may play a role in regulation of E-cadherin.
Increased FLCN-Null Epithelial Cell Permeability and Apoptosis Epithelial cell barriers and permeability depend on the preservation of adherens and tight junctions (Frisch and Screaton, 2001 ). Our data show reduced E-cadherin localization in the FLCN-null cellular membrane, which might affect adherens junctions. Hence, we examined whether FLCN is required for the maintenance of cell permeability. Primary AECs isolated from lungs of Flcn f/f mice were treated with empty adenovirus or Cre-recombinase-expressing adenovirus followed by a cell permeability assay using BODIPY-conjugated ouabain (DiPaolo and Margulies, 2012) . Loss of Flcn resulted in increased permeability of primary AECs ( Figure 5H ) compared to cells expressing Flcn. In addition, loss of Flcn was associated with elevated cleaved caspase-3 levels and an increased number of cells with DNA fragmentation detected by TUNEL assay (Figures 5I-5K ). These data demonstrate that FLCN is required for the maintenance of epithelial barrier integrity and AEC survival.
Similarly, mouse epithelial NMuMG cells transfected with siRNA Flcn exhibited decreased membrane localization of E-cadherin ( Figures 6A and S5A ). siFlcn also significantly decreased protein levels ( Figure S5B ) and cdh1 (E-cadherin) and stk11 (LKB1) gene expression ( Figures S5D and S5F) . Furthermore, in cells transfected with siFlcn, E-cadherin does not maintain its multimeric structure as demonstrated by the presence of lower molecular weight staining under native conditions ( Figure S5C ), in contrast to no differences in LKB1 multimeric structure ( Figure S5E ) detected by native gel electrophoresis with equal loading of E-cadherin or LKB1 proteins.
Loss of Flcn in NMuMG cells also reduced transepithelial resistance (TER) (Figure 6B ), another measure of increased cell permeability (Zheng and Cantley, 2007) . We could not use TER to measure the permeability of primary AECs because they grow on the Matrigel-coated plates, which impede TER measurements. Finally, Flcn knockdown in NMuMG cells also increased cleaved caspase-3 levels ( Figure 6C ) and apoptosis ( Figure 6D ). Analysis of apoptotic gene expression using RT 2 Profiler PCR Arrays (SABiosciences; QIAGEN) revealed proapoptotic gene upregulation and decreased expression of prosurvival genes by Flcn knockdown (Figures S6A-S6C) . Flcn-dependent downregulation of prosurvival Bcl-2 gene was further confirmed by decreased levels of Bcl-2 protein levels ( Figure S6D) . Collectively, our data show that FLCN regulates membrane localization of E-cadherin, protein, and gene expression, maintains epithelial barrier function, and preserves epithelial cell survival.
AICAR and Constitutively Active AMPK Rescue FLCN-Deficient Cell Survival Flcn knockdown visibly changes epithelial cell morphology with disruption of the cell monolayer ( Figure 6E ). To evaluate the role of AMPK in FLCN-deficient cell survival, mouse epithelial NMuMG cells were transfected with siFlcn and then treated with 5-aminoimidizole-4-carboxamide riboside (AICAR), a cellpermeable precursor of AMP that activates AMPK ( Figure 6G ). Treatment with AICAR reversed Flcn-induced disruption of epithelial cell morphology ( Figure 6E ). AICAR treatment also significantly reduced Flcn-induced DNA fragmentation (Figure 6H ) and epithelial cell death ( Figure 6I ). Similar results were seen upon transduction with adenovirus expressing the constitutively active AMPK (AdAMPK-CA) ( Figure 6F ) of NMuMG cells after Flcn knockdown. Expression of constitutively active AMPK markedly improved Flcn-deficient cell morphology (Figure 6E) , reduced DNA fragmentation ( Figure 6H) , and rescued epithelial cell survival ( Figure 6I ). These results demonstrate that the kinase activity of AMPK is required for cell survival in the absence of FLCN. (Figure 7A ). In addition, we measured surface tension of LA phospholipids by a capillary surfactometer (Guttentag et al., 2005) . The capillary surfactometer measures the ability of airflow to progress through a fluid-filled capillary. The capillary openness, as a percentage of capillary diameter, is inversely related to the surface tension of the fluid in the capillary. LA phospholipids from Dox-treated Flcn f/f :SP-C-Cre mice exhibited increased surface tension compared to untreated littermates, as evidenced by reduced capillary openness ( Figure 7B ). Importantly, Figures 7C and 7E-7G, respectively) . Thus, Flcn deletion in lung epithelium induces a physiologically significant aberration in surface tension of alveolar phospholipids that is stabilized by AICAR treatment.
AICAR Improves Alveolar Surface Tension in
AICAR Suppresses Inflammation and MMP Levels
Increased inflammation and proteolytic degradation of extracellular matrix components such as basement membrane or interstitial stroma are pathological changes characteristic of emphysema. To test whether loss of Flcn was associated with increased inflammation, we examined the BAL fluid for inflammatory cell influx. After 2 weeks on a Dox diet, Flcn f/f :SP-CCre mice had increased numbers of total BAL cells compared with mice on a regular diet that was further increased by 6 weeks on Dox ( Figures S6 and 7D) . Importantly, Dox-treated Flcn f/f :SP-C-Cre mice treated with AICAR exhibited decreased inflammatory cell influx ( Figure 7D ). We examined the proinflammatory cytokine profile of BAL from Dox-treated Flcn f/f :SP-C-Cre mice and untreated littermates to determine whether loss of FLCN alters cytokine expression. We found marked elevations in interleukin-6 (IL-6) and macrophage chemotactic protein-1 (MCP-1) in Flcn f/f :SP-C-Cre mice on Dox compared to untreated littermates ( Figures 7H and 7I ). There were no significant differences between control mice and mice with Flcn deletion in AECs in the levels of eotaxin, granulocyte-macrophage colony-stimulating factor, interferon g, tumor necrosis factor a, IL-10, IL-13, IL-1b, keratinocyte chemoattractant, transforming growth factor b1, vascular endothelial growth factor, and macrophage inflammatory protein 1a (data not shown). Moreover, AICAR treatment lowered levels of IL-6 and MCP-1 in BAL fluid of mice with Flcn knockout.
MMPs represent a family of structurally and functionally related enzymes responsible for the proteolytic degradation of extracellular matrix and have been mechanistically linked with progressive pulmonary emphysema and chronic inflammation. BAL from Dox-treated Flcn f/f :SP-C-Cre mice demonstrated significant elevations of MMP-3 and MMP-9 compared to untreated mice ( Figures 7J and 7K) . Furthermore, treatment with AICAR lowered MMP-3 and MMP-9 levels to levels comparable to control mice ( Figures 7J and 7K ). Collectively, in vivo experiments demonstrate that Flcn inactivation in lung AECs of Flcn f/f :SP-CCre mice evokes inflammatory response and upregulation of MMP-3 and MMP-9 in a manner that is reversible with exogenous AMPK activation by AICAR.
DISCUSSION
The present study identifies FLCN as a regulator of lung homeostasis and advances our understanding of the pathophysiology of emphysema. This study details the cellular and molecular mechanisms by which FLCN contributes to lung epithelial cell survival, thereby maintaining alveolar surface tension through maintenance of phospholipid production. As such, loss of FLCN leads to loss of epithelial cells with resultant reduction in phospholipid production that contributes to the lung changes associated with BHD ( Figure 7L ). Furthermore, we show that FLCN maintains epithelial cell junctions and survival in an AMPK-dependent fashion by regulating membrane localization of E-cadherin and LKB1 ( Figure 7L ). The abnormal enlargement of airspaces is a major pathological manifestation of many common and rare lung diseases, including emphysema, cystic fibrosis, chronic obstructive pulmonary disease (COPD), pulmonary lymphangioleiomyomatosis (LAM), pulmonary Langerhans cell histiocytosis (PLCH), lymphocytic interstitial pneumonia (LIP), follicular bronchiolitis, lightchain deposition disease, Sjö gren's syndrome, and amyloidosis (Gupta et al., 2013) . It is becoming increasingly clear that the mechanisms underlying the development of emphysematous changes in the lung are more complex than simply an imbalance of proteolysis and antiproteolysis. Together, our data provide additional supportive evidence for the complex pathophysiology of emphysematous alveolar enlargement by showing that FLCN supports cell survival and influences the cytokine and MMP milieu in ways that might contribute to lung cyst formation with loss of FLCN in BHD. These insights into the role of FLCN may serve as a foundation for novel therapeutic approaches for BHD and other emphysematous lung diseases.
This study establishes that FLCN plays an important physiological role in regulating AEC survival and alveolar integrity. We demonstrate the importance of FLCN for AEC apoptosis in vivo and in vitro using Flcn f/f :SP-C-Cre mice, by examining both lung tissue and isolated AECs. It is intriguing that Flcn loss in an immortalized mouse embryonic stem cell line resulted in transcriptional downregulation of proapoptotic protein Bim (Cash et al., 2011) . Elucidating a more direct role for Flcn intersecting with apoptotic pathways will be possible in the future with our cell and mouse models.
Our studies clearly demonstrate that the prosurvival role is mediated through AMPK ( Figure 7L ). The prosurvival role of AMPK in epithelial cells is well established, especially as related to the maintenance of epithelial contacts and polarity (Zhang et al., 2006; Zheng and Cantley, 2007) . Phosphorylation of AMPK by tumor suppressor LKB1 increases AMPK activity (Jansen et al., 2009 ). This requires the localization of LKB1 to E-cadherin at adherens junctions (Sebbagh et al., 2009 ). Evidence suggesting a role for AMPK in microtubule formation via CLIP-170 (Nakano et al., 2010) , which also has a role in Ecadherin localization (Barnes, 2010) , provides a reinforcing loop of E-cadherin/LKB1/AMPK regulation of apical polarity. Our data suggest that FLCN promotes survival of AECs through this E-cadherin/ LKB1/AMPK axis. Our data also suggest that FLCN functions upstream of AMPK. Loss of FLCN affects assembly of adherens junctions via downregulation of Ecadherin levels while having little effect on ZO1 levels in tight junctions. Importantly, disruption of the epithelial monolayer and apoptosis caused by FLCN loss were prevented by either molecular or pharmacological AMPK activation. Together with published studies, our data suggest that FLCN is required for E-cadherindependent epithelial cell-cell junctions, impairment of LKB1-AMPK signaling, and caspase-dependent apoptosis of lung AECs, the initial component of alveolar airspace enlargement. Further studies will provide detailed mechanisms of how FLCN regulates E-cadherin and LKB1 expressions.
One consequence of altered AEC survival is the loss of an important source of pulmonary phospholipids. Phospholipids play an important role in the maintenance of alveolar stability through the respiratory cycle, so it is perhaps not surprising that apoptosis-induced airspace enlargement is associated with increased alveolar surface tension, and alveolar instability and collapse (Mouded et al., 2009 ). However, this raises an important therapeutic possibility, specifically the potential for exogenous phospholipid therapy to mitigate the effects of AEC loss. Although exogenous phospholipid therapy for unintubated patients is currently unfeasible due to issues of delivery, novel delivery modalities or therapies targeting increased production of phospholipid by the remaining epithelial cell population are attractive options for the future.
The loss of FLCN also evokes an inflammatory response associated with local production of inflammatory cytokines and MMPs. Further studies will determine whether this is due to an epithelial injury response, or whether FLCN itself signals an anti-inflammatory pathway.
FLCN acts through an AMPK-mediated pathway that can be resurrected by exogenous activation of AMPK. AICAR, an AMPK activator, reverses many of the pathologic changes in the Flcn f/f :SP-C-Cre mice with Flcn deletion limited to lung AECs. Importantly, AICAR rescues those features of Flcn loss that are critical to the pathophysiology of lung cysts, specifically mitigating inflammation and MMP expression that propagate local alveolar damage and enhancing phospholipid production to stabilize airspace inflation. Although AMPKdependent suppression of MMP-9 has been previously reported by Hwang and Jeong (2010) and Morizane et al. (2011) , our data provide an attractive mechanism for a feedforward cycle of epithelial cell destabilization with loss of FLCN followed by further local destruction by enhanced MMP production. Further studies are needed to establish the mechanism(s) whereby impaired AMPK signaling increases MMP expression.
Rescue by AICAR does not reverse the structural changes due to FLCN loss. It does not rule out the possibility that AMPK agonists may have a role in prevention or that they may be useful to stop or slow the progression of existing emphysema.
There are several limitations of our studies. First, Flcn deletion in Flcn f/f :SP-C-Cre mice does not precisely phenocopy lung changes in patients with BHD. Patients with BHD exhibit loss of alveoli and lung cyst development predominantly localized to the lower regions of the lung (Gupta et al., 2013) . The differences between our mouse model and human patients may be due to either the restricted knockout of Flcn in epithelial cells only or the expression of nonnull mutations of FLCN in patients with BHD. Despite these limitations, our data demonstrate the key role of FLCN in the maintenance of normal lung parenchyma architecture and physiology, and a well-defined mechanism whereby FLCN, acting through E-cadherin, LKB1, and AMPK, has a critical role in regulating the assembly of epithelial cell junctions.
EXPERIMENTAL PROCEDURES
The Human Lung Tissue Control human lung tissues from three subjects were obtained from the National Disease Research Interchange, and the human BHD tissue samples from four patients with BHD were obtained from the NIH under approved protocols.
Animals
Flcn f/f :SP-C-Cre mice were generated by crossing Flcn f/f mice with SP-C-rtTA/tetO-Cre (line 2) mice (Perl et al., 2009 (Perl et al., 2009) . Genotyping was performed as described . Six-week-old male Flcn f/f :SP-C-Cre or Flcn f/f :CCSP-CCre mice were transferred on chow supplemented with 2.5% Dox (Dox+) or maintained on a regular chow (DoxÀ) for 3 or 6 weeks. Treatment with 500 mg/kg AICAR was performed daily by intraperitoneal injections for 6 weeks in mice on DoxÀ or Dox+ diet. Lung function was measured on a computerized FlexiVent System (SCIREQ) (Haczku et al., 2002) . For morphological analyses, lungs were inflated at constant 25 cm H 2 O pressure with 1:1 optimal cutting temperature/PBS or low-melting agarose in PBS for approximately 8 min (Goncharova et al., 2012) . Each experimental group included a minimum of five animals per condition. Experiments to determine the effects of Flcn loss on alveoli space enlargement were performed three times, and experiments with treatment by AICAR were performed twice. All animal procedures were performed according to a protocol approved by the University of Pennsylvania IACUC.
BAL Analyses
BAL fluid was collected by lavaging the lung with 1 ml of sterile saline to a total of 5 ml. Recovered BAL was centrifuged 400 3 g for 10 min at 4 C, then cell pellet was resuspended in 1 ml PBS for total cell count. Cell-free BAL supernatants were separated by centrifugation at 20,000 3 g for 60 min at 4 C into LA and small-aggregate (SA) phospholipid fractions. Surface tension was determined by measuring capillary openness with a capillary surfactometer (Calmia Medical) (Guttentag et al., 2005) . Briefly, 0.5 ml of 1 mg/ml LA fraction was deposited into the glass capillary and compressed for 120 s, resulting in a cyclic extrusion from the narrow end of the capillary permitting airflow and capillary patency. Dysfunctional phospholipids exhibit decreased capillary patency that is inversely correlated with the surface tension. A microprocessor calculates the percentage of the 120 s period that the capillary is open to free airflow. Each sample was analyzed in triplicate. Cytokine and MMPs were determined in the cell-free BAL by SearchLight Multiplex ELISA at Aushon Biosystems.
Morphometry
Images of lung tissue sections stained with H&E were acquired with a Nikon Eclipse 80i microscope under 1003 magnification. Ten randomly selected fields per slide from three nonserial sections were analyzed. Image-Pro Plus 6.2 software (Media Cybernetics) was used to measure the MAAA and MLI. Airway, vascular structures, and histological mechanical artifacts were eliminated from the analysis. Immunohistochemical, immunocytochemical, and immunoblot analyses were performed as described (Goncharova et al., 2011) . Immunostaining was visualized with a Leica SP5 X or Zeiss LSM 700 confocal microscope or a Nikon Eclipse TE2000-E microscope equipped with an Evolution QEi digital video camera under appropriate filters. Protein levels were analyzed by optical density with Gel-Pro Analyzer software.
Cell Culture
AECs were isolated from 2-week-old Flcn f/f mice as described (Atochina-Vasserman et al., 2011) . Mouse lungs were inflated in situ via tracheal cannulation with dispase. Dissected lobes were digested in modified Eagle's medium plus DNase I. The mixed cells were filtered, and fibroblasts were removed from the suspension by three successive adherence steps on plastic. Negative selection was used to purify epithelial cells from macrophages and other blood cells using magnetic beads (Dynal Mouse T Cell Negative Isolation Kit #114.13D). Cells were plated in HITES medium (prepared in Ham's F12 plus 15 mM HEPES, 0.8 mM CaCl2, hydrocortisone, and b-estradiol) plus 10% fetal calf serum (FCS) on coverslips coated with 10% Matrigel (BD Biosciences) for immunofluorescence staining. Serum was added for 48 hr to facilitate adherence and was then removed to minimize overgrowth of any remaining fibroblasts. Human UOK-257 and UOK257-2 cell lines (Hong et al., 2010 ) and TSC2-null kidney epithelial cells from an Eker rat were prepared as described by Kleymenova et al. (2001) ; mouse epithelial NMuMG cells were purchased from the American Type Culture Collection. Flcn siRNA was from Dharmacon, and scrambled siRNA was from Santa Cruz Biotechnology. Transfection was performed using Effectene or RNAiFect reagents (QIAGEN). Infection with AdCre or AdFLCN adenovirus was described (Goncharova et al., 2004) .
BODIPY Permeability Assay
The assay was performed as described (DiPaolo and Margulies, 2012) . Briefly, 2 mm BODIPY-ouabain (Invitrogen) was added to AECs for 1 hr. Then BODIPYouabain fluorescence was visualized using a green emission filter. Fluorescence was measured on four separate fields per well, and three wells were measured per condition. All measurements were normalized to values from cells infected with control adenovirus.
TER Measurements TER was measured in confluent NMuMG cells, grown on electric cell substrate impedance-sensing (ECIS) 8W1E plates, then subjected to an elevated voltage pulse of 40 kHz frequency, 3.5 V amplitude for 30 s (Taliaferro-Smith et al., 2009 ).
Data Analysis
Data points from individual assays represent mean ± SE. Statistically significant differences among groups were assessed with ANOVA (with the Fisher post hoc least significant difference test), with values of p < 0.05 to sufficiently reject the null hypothesis for all analyses. In Figures 7 and S7 , statistically significant differences among groups were assessed with t test (n = 5-7 animals per group). All experiments were designed with matched control conditions within each experiment (minimum of five animals) to enable statistical comparison as paired samples and to obtain statistically significant data.
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